NUVA - NuVasive, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
61.53
+0.49 (+0.80%)
At close: 4:00PM EDT

61.53 0.00 (0.00%)
After hours: 4:35PM EDT

Stock chart is not supported by your current browser
Trade prices are not sourced from all markets
Previous Close61.04
Open61.07
Bid59.88 x 1300
Ask61.65 x 1800
Day's Range60.83 - 61.61
52 Week Range43.51 - 72.41
Volume359,054
Avg. Volume539,400
Market Cap3.193B
Beta (3Y Monthly)1.40
PE Ratio (TTM)65.95
EPS (TTM)0.93
Earnings DateJul 29, 2019 - Aug 2, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est62.20
  • Markit3 days ago

    See what the IHS Markit Score report has to say about NuVasive Inc.

    NuVasive Inc NASDAQ/NGS:NUVAView full report here! Summary * Bearish sentiment is moderate and increasing Bearish sentimentShort interest | NeutralShort interest is moderate for NUVA with between 5 and 10% of shares outstanding currently on loan. This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on May 1. Money flowETF/Index ownership | NeutralETF activity is neutral. The net inflows of $2.16 billion over the last one-month into ETFs that hold NUVA are not among the highest of the last year and have been slowing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • VREX vs. NUVA: Which Stock Is the Better Value Option?
    Zacks10 days ago

    VREX vs. NUVA: Which Stock Is the Better Value Option?

    VREX vs. NUVA: Which Stock Is the Better Value Option?

  • NuVasive To Participate As Global Partner At 12th Annual Society Of Lateral Access Surgery Meeting
    PR Newswire10 days ago

    NuVasive To Participate As Global Partner At 12th Annual Society Of Lateral Access Surgery Meeting

    SAN DIEGO, May 14, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company continues its commitment to the Society of Lateral Access Surgery (SOLAS) as a Global Partner, the leading sponsorship level in the partnership program, at the 12th annual SOLAS meeting being held May 16-18, 2019 in Miami, Florida. NuVasive will also participate in exhibit and workshop programs, featuring its comprehensive approach to lateral single-position surgery with the X360™ system integrated with Surgical Intelligence™. During the meeting, NuVasive will host a lunch symposia, X360 powered by Surgical Intelligence, presented by Brett Braly, MD, and Brian Kwon, MD, on May 17, 2019 from 12:45 to 2:15 p.m. ET.

  • NuVasive To Present At The Bank of America Merrill Lynch Healthcare Conference 2019
    PR Newswire18 days ago

    NuVasive To Present At The Bank of America Merrill Lynch Healthcare Conference 2019

    A live webcast of the presentation will be available online from the Investor Relations page of the Company's website at www.nuvasive.com. NuVasive, Inc. (NUVA) is the leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. With more than $1 billion in revenues, NuVasive has approximately 2,600 employees and operates in more than 50 countries serving surgeons, hospitals and patients.

  • How NuVasive, Inc. (NASDAQ:NUVA) Can Impact Your Portfolio Volatility
    Simply Wall St.18 days ago

    How NuVasive, Inc. (NASDAQ:NUVA) Can Impact Your Portfolio Volatility

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Anyone researching NuVasive, Inc. (NASDAQ:NUVA) might want to consider the historical volatility of t...

  • Thomson Reuters StreetEvents19 days ago

    Edited Transcript of NUVA earnings conference call or presentation 1-May-19 8:30pm GMT

    Q1 2019 NuVasive Inc Earnings Call

  • NuVasive (NUVA) Q1 Earnings Top Estimates, Margins Strong
    Zacks22 days ago

    NuVasive (NUVA) Q1 Earnings Top Estimates, Margins Strong

    NuVasive's (NUVA) solid international sales in Q1 boost investor confidence in the stock.

  • NuVasive Inc (NUVA) Q1 2019 Earnings Call Transcript
    Motley Fool23 days ago

    NuVasive Inc (NUVA) Q1 2019 Earnings Call Transcript

    NUVA earnings call for the period ending March 31, 2019.

  • NuVasive Straightens Up to Start 2019
    Motley Fool23 days ago

    NuVasive Straightens Up to Start 2019

    The spinal-surgery specialist gave investors solid performance.

  • NuVasive (NUVA) Q1 Earnings and Revenues Top Estimates
    Zacks23 days ago

    NuVasive (NUVA) Q1 Earnings and Revenues Top Estimates

    NuVasive (NUVA) delivered earnings and revenue surprises of 29.27% and 2.21%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press23 days ago

    NuVasive: 1Q Earnings Snapshot

    The San Diego-based company said it had net income of 18 cents per share. Earnings, adjusted for amortization costs and non-recurring costs, came to 53 cents per share. The results surpassed Wall Street ...

  • NuVasive Announces First Quarter 2019 Financial Results
    PR Newswire23 days ago

    NuVasive Announces First Quarter 2019 Financial Results

    SAN DIEGO , May 1, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated ...

  • Benzinga23 days ago

    A Preview Of NuVasive's Q1 Earnings

    On Wednesday, May 1, NuVasive (NASDAQ: NUVA ) will release its latest earnings report. Check out Benzinga's preview to understand the implications. Earnings and Revenue NuVasive earnings will be near 41 ...

  • Is NuVasive, Inc. (NUVA) A Good Stock To Buy?
    Insider Monkey25 days ago

    Is NuVasive, Inc. (NUVA) A Good Stock To Buy?

    Amid an overall market correction, many stocks that smart money investors were collectively bullish on tanked during the fourth quarter. Among them, Amazon and Netflix ranked among the top 30 picks and both lost more than 25%. Facebook, which was the second most popular stock, lost 20% amid uncertainty regarding the interest rates and tech […]

  • NuVasive (NUVA) Reports Next Week: Wall Street Expects Earnings Growth
    Zackslast month

    NuVasive (NUVA) Reports Next Week: Wall Street Expects Earnings Growth

    NuVasive (NUVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Clinical Study Demonstrates NuVasive Cohere® Porous PEEK™ Spinal Interbody Promotes Improved Early Outcomes Over Structural Allograft And Smooth PEEK
    PR Newswirelast month

    Clinical Study Demonstrates NuVasive Cohere® Porous PEEK™ Spinal Interbody Promotes Improved Early Outcomes Over Structural Allograft And Smooth PEEK

    SAN DIEGO, April 22, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the results of the study "Early Clinical Outcomes Comparing Porous PEEK, Smooth PEEK, and Structural Allograft Interbody Devices for Anterior Cervical Discectomy and Fusion," published online in the Journal of Spine & Neurosurgery, which concludes that the NuVasive proprietary Cohere® Porous polyetheretherketone (PEEK) implant demonstrates a clear benefit in promoting improved early outcomes over structural allograft and smooth PEEK in anterior cervical discectomy and fusion (ACDF) procedures. In the study, 167 patients presenting with degenerative cervical disc disease underwent ACDF using Cohere Porous PEEK™, structural allograft or smooth PEEK in the interbody space.

  • NuVasive Announces Conference Call And Webcast Of First Quarter 2019 Results
    PR Newswirelast month

    NuVasive Announces Conference Call And Webcast Of First Quarter 2019 Results

    SAN DIEGO, April 15, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its first quarter 2019 earnings results on Wednesday, May 1, 2019 after the close of the market. NuVasive will hold a conference call on Wednesday, May 1, 2019, at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results of its financial performance for the first quarter 2019. The dial-in numbers are 1-877-407-9039 for domestic callers and 1-201-689-8470 for international callers.

  • Nuvasive Advances Lateral Single-Position Surgery With Introduction Of X360™ System At AANS 2019
    PR Newswirelast month

    Nuvasive Advances Lateral Single-Position Surgery With Introduction Of X360™ System At AANS 2019

    Integrated Procedural System Advances Approach to Minimally Invasive Surgery SAN DIEGO , April 11, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused ...

  • NuVasive LessRay® Platform Wins Top Honor At 2019 Edison Awards
    PR Newswire2 months ago

    NuVasive LessRay® Platform Wins Top Honor At 2019 Edison Awards

    SAN DIEGO, April 5, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its LessRay® radiation reduction and workflow enhancement platform was voted a gold winner in the advanced surgical instruments category at the 2019 Edison Awards™ held in New York City on April 4. The LessRay platform is built on a proprietary algorithm that captures and enhances low-dose, low-quality images to produce images with similar diagnostic capabilities as conventional full-dose images. This technology has the ability to reduce radiation emissions to the operating room (OR) staff and patient by 75 percent compared to standard fluoroscopy.1 Also included in this multi-functional platform are tools designed to increase OR efficiency through streamlined surgical workflow and redefined anatomical visualization.

  • NuVasive (NUVA) Completes First COHERE XLIF Case in U.S.
    Zacks2 months ago

    NuVasive (NUVA) Completes First COHERE XLIF Case in U.S.

    NuVasive's (NUVA) Advanced Materials Science implant portfolio will be fortified by the incorporation of the Porous PEEK technology into its implants for lateral single-position surgery.

  • NuVasive Proprietary Porous PEEK™ Technology Used In First XLIF® Spine Surgery Cases
    PR Newswire2 months ago

    NuVasive Proprietary Porous PEEK™ Technology Used In First XLIF® Spine Surgery Cases

    SAN DIEGO, April 1, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the first-case uses of Cohere® XLIF, the first-of-its-kind lateral Porous PEEK™ implant for XLIF® and lateral single-position surgery. The NuVasive Advanced Materials Science™ implant portfolio will remain on the forefront of innovation by incorporating Porous PEEK technology into its implants for lateral single-position surgery and beyond.

  • NuVasive (NUVA) Down 1% Since Last Earnings Report: Can It Rebound?
    Zacks2 months ago

    NuVasive (NUVA) Down 1% Since Last Earnings Report: Can It Rebound?

    NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.